OMXS BENCH GI Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
| Current Valuation | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | AZN | AstraZeneca PLC ADR | (0.27) | 1.53 | (0.41) | ||
| 2 | EQT | EQT Corporation | 0.23 | 2.18 | 0.51 | ||
| 3 | SF | Stifel Financial | 0.22 | 2.14 | 0.47 | ||
| 4 | BILL | Bill Com Holdings | 0.25 | 3.44 | 0.85 | ||
| 5 | SAND | Sandstorm Gold Ltd | 0.01 | 2.39 | 0.02 | ||
| 6 | EVO | Evotec SE ADR | 0.10 | 5.78 | 0.55 | ||
| 7 | BRAV | Bravada Intl | 0.00 | 0.00 | 0.00 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.